News Image

Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)

Provided By GlobeNewswire

Last update: Jul 14, 2025

July 14, 2025

Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in

Familial Adenomatous Polyposis (FAP)

Read more at globenewswire.com

BIODEXA PHARMACEUTICALS-ADR

NASDAQ:BDRX (12/19/2025, 8:00:01 PM)

After market: 3.67 +0.03 (+0.82%)

3.64

-0.51 (-12.29%)


Find more stocks in the Stock Screener

BDRX Latest News and Analysis

6 days ago - By: Chartmill - Mentions: IRBT NCI SUPX ASTI ...
News Image
6 days ago - By: Chartmill - Mentions: IRBT NCI RILY PLAG ...
News Image
7 days ago - By: Chartmill - Mentions: ASTI DXLG YCBD RZLT ...
News Image
7 days ago - By: Chartmill - Mentions: IRBT NCT ASNS PCSA ...
News Image
11 days ago - By: Chartmill - Mentions: IRBT LAKE BEAT PLAB ...
News Image
12 days ago - By: Chartmill - Mentions: IBIO RETO OCG SNTI ...
News Image
12 days ago - By: Chartmill - Mentions: LAKE BEAT MIND PLAB ...
News Image
12 days ago - By: Chartmill - Mentions: ALEX TROX CMCT CETX ...
News Image
13 days ago - By: Chartmill - Mentions: ALEX TROX CMCT CETX ...
News Image
13 days ago - By: Chartmill - Mentions: STAA ALEX TROX CMCT ...
News Image
13 days ago - By: Chartmill - Mentions: ALEX WHLR CMCT CAL ...
News Image
13 days ago - By: Chartmill - Mentions: CEP RPRX FGL CMCT ...
News Image
Follow ChartMill for more